Drugs / PRO-118
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01541904 | Mar 2011 → Feb 2012 | conjunctivitis, eye allergy | Laboratorios Sophia S.A de C.V. | Withdrawn | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01657240 | Nov 2014 → Apr 2015 | conjunctivitis | Laboratorios Sophia S.A de C.V. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-118 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01541904 ↗ |
| Route | Other | “pro-118 ophthalmic solution, instill one drop in each eye once a day for 21 days” NCT01657240 ↗ |